Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab | Journal for ImmunoTherapy of Cancer
L'ONCOLOGIA MEDICA DI PRECISIONE TRA RICERCA DI BASE E TRATTAMENTI INNOVATIVI
Conference Programme
REGIONE TOSCANA
Health Evidence Review Commission's Value-based Benefits Subcommittee
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
Forza ciclo continuo tendono dott francesco cappellini Coerente costola Rispetto